Literature DB >> 24196626

[Mesenchymal stroma cells and their niche].

R K Schneider1.   

Abstract

Stem cells reside in a highly specialized, complex microenvironment that is known as the stem cell niche. The stem cell niche can be described as an anatomically defined space where the stem cell is localized and nourished and stem cell quiescence, proliferation and differentiation are maintained. Tissue engineering aims to imitate the stem cell niche to (I) induce a directed differentiation, (II) maintain the self-renewal capacity or (III) find a regulated balance between self-renewal and differentiation. Mesenchymal stem or stromal cells (MSC) can differentiate in three-dimensional collagen gels into functional osteoblasts when subjected to a phosphate-rich cultivation medium. Furthermore, they acquire a prosynthetic, matrix remodeling, contractile phenotype. Medial artery calcification in patients with chronic kidney disease also proceeds through intramembranous ossification resulting from osteoblast-induced calcification of the collagen extracellular matrix. Thus, the influence of uremic cultivation conditions as a pathophysiological stimulus on MSC and endothelial cells was analyzed with special regards to matrix remodeling, vascularization and calcification. The results showed that BMP-2/4 mediated MSC (mal)differentiation into osteoblasts with acquired matrix remodeling phenotype and loss of proangiogenic capacity. These studies have led to the conclusion that uremia has detrimental effects on the stem cell niche and promotes the continuous calcification by osteogenic (mal)differentiation. In summary, recent studies have shown the conducting and regulating effect of the stem cell niche under physiological conditions that can be applied and mimicked for tissue engineering applications. However, under pathological conditions the stem cell niche can have detrimental effects on stem cell function and can promote disease progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24196626     DOI: 10.1007/s00292-013-1818-6

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  32 in total

1.  Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification.

Authors:  Kerry L Tyson; Joanne L Reynolds; Rosamund McNair; Qiuping Zhang; Peter L Weissberg; Catherine M Shanahan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

2.  Bone morphogenetic protein-2 may represent the molecular link between oxidative stress and vascular stiffness in chronic kidney disease.

Authors:  G Dalfino; S Simone; S Porreca; C Cosola; C Balestra; C Manno; F P Schena; G Grandaliano; G Pertosa
Journal:  Atherosclerosis       Date:  2010-04-29       Impact factor: 5.162

3.  [Mesenchymal stem cells for bone tissue engineering].

Authors:  R K Schneider; S Neuss; R Knüchel; A Perez-Bouza
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

4.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

Authors:  E M Horwitz; K Le Blanc; M Dominici; I Mueller; I Slaper-Cortenbach; F C Marini; R J Deans; D S Krause; A Keating
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

5.  The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds.

Authors:  Rebekka K Schneider; Andrea Puellen; Rafael Kramann; Kerstin Raupach; Jörg Bornemann; Ruth Knuechel; Alberto Pérez-Bouza; Sabine Neuss
Journal:  Biomaterials       Date:  2009-10-07       Impact factor: 12.479

Review 6.  Stromal stem cells: marrow-derived osteogenic precursors.

Authors:  M Owen; A J Friedenstein
Journal:  Ciba Found Symp       Date:  1988

Review 7.  Vascular calcification: pathobiological mechanisms and clinical implications.

Authors:  Rebecca C Johnson; Jane A Leopold; Joseph Loscalzo
Journal:  Circ Res       Date:  2006-11-10       Impact factor: 17.367

8.  Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory.

Authors:  K E Watson; F Parhami; V Shin; L L Demer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-12       Impact factor: 8.311

9.  Bone morphogenetic protein expression in human atherosclerotic lesions.

Authors:  K Boström; K E Watson; S Horn; C Wortham; I M Herman; L L Demer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

View more
  1 in total

Review 1.  [The emerging technology of tissue engineering : Focus on stem cell niche].

Authors:  U Schlötzer-Schrehardt; U Freudenberg; F E Kruse
Journal:  Ophthalmologe       Date:  2017-04       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.